Name | SymBio Pharmaceuticals Limited | ||
Address | Toranomon 30 Mori Bldg., 3-2-2 Toranomon, Minato-ku, Tokyo 105-0001, Japan Tel: +81-3-5472-1125 Fax: +81-3-5472-3054 For inquiry about brincidofovir: +81-3-6684-6663 |
||
Established | March 25, 2005 | ||
Capital stock | JPY17,548,459,551 (at the end of December 2022) | ||
Board of Directors | Fuminori Yoshida | Representative Director | |
Shigetoshi Matsumoto | Board Director <Outside> | ||
Bruce David Cheson | Board Director <Outside> | ||
Eiji Ebinuma | Board Director <Outside> | ||
Kiyoshi Watanabe | Board Director, Full-Time Audit & Supervisory Committee Member<Outside> | ||
Kesao Endo | Board Director, Audit & Supervisory Committee Member<Outside> | ||
Yasuhiro Tamo | Board Director, Audit & Supervisory Committee Member<Outside> | ||
Corporate Officers | Fuminori Yoshida | Corporate Officer, President and Chief Executive Officer | |
Takaaki Fukushima | Executive Corporate Officer, Chief Financial Officer | ||
Koji Fukushima | Corporate Officer, Chief Medical Officer | ||
Yoshiharu Torikai | Corporate Officer | ||
Masahiko Okuno | Corporate Officer | ||
Hiroyuki Horita | Corporate Officer | ||
Subsidiary | SymBio Pharma USA, Inc. Durham, North Carolina, USA Carolyn YanavichPresident and Chief Operating Officer |